FAK-Src-paxillin system expression and disease outcome in human neuroblastoma.
Pediatr Hematol Oncol. 2017 Oct 17;:1-10
Authors: Kratimenos P, Koutroulis I, Syriopoulou V, Michailidi C, Delivoria-Papadopoulos M, Klijanienko J, Theocharis S
Abstract BACKGROUND: Neuroblastoma (NB) often presents with metastatic disease and poor survival. The need for new prognostic markers remains invaluable.